Posted on 20th November 2011
Scientists in in Australia have just completed a study involving 10,000 patients aged between 50 and 75. Patients taking the drug, fenofibrate, were found to reduce their risk of needing laser treatment (a normal treatment diabetic eye disease) by a third. Fenofibrate is a lipid-modifying agent that helps to reduce complications in diabetic retinopathy. Professor Ian Young from Queen’s University, Belfast who lead the study has urged the National Institute for Clinical Excellence (NICE) to recommend using the drug in the NHS.
18th June 2018
We’re thrilled to announce that our clinical lead optometrist, Gillian Bruce, has passed her Masters of Science (MSc) degree in Primary Care Ophthalmology with distinction. As if that wasn’t impre...Read more
24th May 2018
When we first wrote in our blog about Myopia Management over two years ago, it was all quite new. Cameron Optometry was one of the first optometrists in the UK to set up a Myopia Management programme ...Read more